Identification and assessment of PLK1/2/3/4 in lung adenocarcinoma and lung squamous cell carcinoma: Evidence from methylation profile

Journal of Cellular and Molecular Medicine

Sisi Deng¹  Xiaoli Lu¹  Zhi Zhang¹  Rui Meng¹  Shilin Xia²  Mi Li³ 

[1] Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China;Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, China;Department of Palliative Medicine, Graduate School of Medicine, Juntendo University, Tokyo, Japan;Department of Orthopedics, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China;Shenzhen Huazhong University of Science and Technology Research Institute, Shenzhen, China;

关键词: lung adenocarcinoma;    lung squamous cell carcinoma;    methylation;    PLK1/2/3/4;   

DOI  :  10.1111/jcmm.16668

来源: Wiley

【 授权许可】

CC BY